Pilot trial of high-dose vitamin C in critically ill COVID-19 patients

[1] Tian S(2020)Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer J Thorac Oncol 15 700-704

[2] Hu W(2020)A novel coronavirus emerging in china - key questions for impact assessment N Engl J Med 382 692-694

[3] Niu L(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-1720

[4] Liu H(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-1062

[5] Xu H(2012)Regulating the adaptive immune response to respiratory virus infection Nat Rev Immunol 12 295-305

[6] Xiao SY(2020)Clinical and immunological features of severe and moderate coronavirus disease 2019 J Clin Investig 130 2620-2629

[7] Munster VJ(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 8 420-422

[8] Koopmans M(2003)Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet 361 1767-1772

[9] van Doremalen N(2015)Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care 19 418-474

[10] van Riel D(2016)Antioxidant vitamins and trace elements in critical illness Nutr Clin Pract 31 457-1035

[1] Tian S(2020)Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer J Thorac Oncol 15 700-704

[2] Hu W(2020)A novel coronavirus emerging in china - key questions for impact assessment N Engl J Med 382 692-694

[3] Niu L(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-1720

[4] Liu H(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-1062

[5] Xu H(2012)Regulating the adaptive immune response to respiratory virus infection Nat Rev Immunol 12 295-305

[6] Xiao SY(2020)Clinical and immunological features of severe and moderate coronavirus disease 2019 J Clin Investig 130 2620-2629

[7] Munster VJ(2020)Pathological findings of COVID-19 associated with acute respiratory distress syndrome Lancet Respir Med 8 420-422

[8] Koopmans M(2003)Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study Lancet 361 1767-1772

[9] van Doremalen N(2015)Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care 19 418-474

[10] van Riel D(2016)Antioxidant vitamins and trace elements in critical illness Nutr Clin Pract 31 457-1035